Ibio Inc (NYSEAMERICAN:IBIO) major shareholder Eastern Capital Ltd bought 12,000,000 shares of the stock in a transaction that occurred on Thursday, November 30th. The shares were purchased at an average price of $0.20 per share, with a total value of $2,400,000.00. Following the purchase, the insider now owns 45,744,000 shares of the company’s stock, valued at approximately $9,148,800. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Ibio Inc (NYSEAMERICAN:IBIO) opened at $0.17 on Tuesday. Ibio Inc has a 12 month low of $0.16 and a 12 month high of $0.56.
COPYRIGHT VIOLATION WARNING: This story was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.chaffeybreeze.com/2017/12/05/ibio-inc-ibio-major-shareholder-eastern-capital-ltd-buys-12000000-shares.html.
Ibio Company Profile
iBio, Inc is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company’s technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants.
Receive News & Ratings for Ibio Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ibio Inc and related companies with MarketBeat.com's FREE daily email newsletter.